XIAOMI-W
01810
BABA-W
09988
POP MART
09992
4
BYD COMPANY
01211
5
TENCENT
00700
HK Stock MarketDetailed Quotes
01858 CHUNLI MEDICAL
- 9.330
- 0.0000.00%
Trading May 2 13:40 CST
3.58BMarket Cap25.84P/E (TTM)
9.600High9.310Low77.00KVolume9.450Open9.330Pre Close730.79KTurnover0.08%Turnover Ratio26.51P/E (Static)383.57MShares11.93252wk High1.15P/B887.66MFloat Cap6.08952wk Low0.49Dividend TTM95.14MShs Float62.017Historical High0.397Dividend LFY3.11%Amplitude0.279Historical Low9.490Avg Price250Lot Size5.23%Div YieldTTM4.26%Div Yield LFY
CHUNLI MEDICAL Key Stats
All
YOY
| (Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 3.60%229.84M | -33.32%805.86M | -35.84%508.28M | -29.70%380.13M | -9.95%221.85M | 0.58%1.21B | 4.24%792.16M | -5.37%540.71M | -4.18%246.36M | 8.43%1.2B |
| Operating income | 3.60%229.84M | -33.32%805.86M | -35.84%508.28M | -29.70%380.13M | -9.95%221.85M | 0.58%1.21B | 4.24%792.16M | -5.37%540.71M | -4.18%246.36M | 8.43%1.2B |
| Operating expenses | -31.93%-76.57M | 19.14%-268.95M | 32.85%-156.04M | 27.50%-108.25M | 25.51%-58.04M | -15.47%-332.64M | -17.08%-232.37M | -2.55%-149.3M | -55.17%-77.92M | -13.60%-288.08M |
| Gross profit | -6.43%153.27M | -38.70%536.9M | -37.08%352.24M | -30.54%271.88M | -2.75%163.81M | -4.12%875.89M | -0.30%559.78M | -8.08%391.41M | -18.59%168.44M | 6.90%913.53M |
| Selling expenses | 26.96%-46.12M | 37.30%-240.25M | 30.07%-163.46M | 33.20%-111.48M | 2.80%-63.15M | 2.13%-383.14M | -1.56%-233.75M | -7.66%-166.89M | 18.69%-64.97M | -14.45%-391.47M |
| Administrative expenses | -120.50%-16.59M | -1.84%-45.29M | -8.46%-31.36M | -12.41%-21.31M | -6.69%-7.52M | -14.50%-44.47M | -17.15%-28.91M | -22.59%-18.96M | -17.28%-7.05M | -26.63%-38.84M |
| Research and development expenses | 23.13%-26.9M | 15.46%-133.1M | 13.13%-99.68M | 9.27%-67.66M | -5.17%-34.99M | 3.02%-157.45M | -9.26%-114.74M | -3.16%-74.57M | -0.47%-33.27M | -54.84%-162.34M |
| Profit from asset sales | ---15.72K | 904.29%39.21K | 7,237.14%39.21K | --39.21K | ---- | -84.57%3.9K | -102.17%-549.43 | ---- | ---- | 70.33%25.31K |
| Revaluation surplus | 16.19%1.6M | -1.83%9.43M | -14.03%6.08M | 6.57%4.67M | -31.73%1.38M | 1.27%9.61M | 8.14%7.07M | 10.60%4.38M | 19.29%2.02M | --9.49M |
| -Changes in the fair value of other assets | 16.19%1.6M | -1.83%9.43M | -14.03%6.08M | 6.57%4.67M | -31.73%1.38M | 1.27%9.61M | 8.14%7.07M | 10.60%4.38M | 19.29%2.02M | --9.49M |
| Impairment and provision | -52.86%-8.37M | -51.72%-37.96M | -43.49%-16.47M | 7.86%-11.02M | 31.10%-5.48M | 17.33%-25.02M | 14.50%-11.48M | 28.70%-11.96M | -58.09%-7.95M | -10.91%-30.27M |
| -Other impairment is provision | -52.86%-8.37M | -51.72%-37.96M | -43.49%-16.47M | 7.86%-11.02M | 31.10%-5.48M | 17.33%-25.02M | 14.50%-11.48M | 28.70%-11.96M | -58.09%-7.95M | -10.91%-30.27M |
| Special items of operating profit | -10.33%5.4M | 27.28%31.59M | 11.86%16.99M | -11.25%12.5M | 10.49%6.02M | 13.14%24.82M | -47.15%15.19M | 128.98%14.08M | 567.34%5.45M | 25.68%21.94M |
| Operating profit | 3.57%60.32M | -60.73%113.65M | -68.86%58.37M | -45.10%73.27M | -4.75%58.24M | -6.26%289.39M | -12.73%187.42M | -20.96%133.47M | -26.22%61.14M | -13.75%308.73M |
| Financing cost | 284.31%4.17M | 2.93%17.07M | -16.81%7.09M | 80.47%9.01M | -9.55%1.08M | -17.81%16.58M | -48.62%8.52M | -13.57%4.99M | -14.82%1.2M | 109.24%20.17M |
| Adjustment items of earning before tax | -100.00%0.04 | 1,370.79%884.48K | 1,530.27%713.98K | 909.91%783.77K | 819.68%839.1K | -100.87%-69.6K | 97.78%-49.92K | 103.46%77.61K | 91.23%-116.59K | 3,843.45%7.97M |
| Earning before tax | 7.18%64.49M | -56.98%131.6M | -66.22%66.16M | -40.04%83.07M | -3.31%60.16M | -9.19%305.91M | -14.49%195.88M | -19.64%138.54M | -24.99%62.23M | -8.30%336.88M |
| Tax | -27.66%-6.46M | 75.30%-6.94M | 66.53%-5.16M | 67.26%-4.11M | 20.53%-5.06M | 3.68%-28.09M | 20.47%-15.4M | 18.57%-12.55M | 28.73%-6.36M | 35.22%-29.16M |
| After-tax profit from continuing operations | 5.31%58.03M | -55.13%124.66M | -66.20%61.01M | -37.33%78.96M | -1.35%55.11M | -9.72%277.82M | -13.94%180.48M | -19.75%125.99M | -24.53%55.86M | -4.54%307.72M |
| Earning after tax | 5.31%58.03M | -55.13%124.66M | -66.20%61.01M | -37.33%78.96M | -1.35%55.11M | -9.72%277.82M | -13.94%180.48M | -19.75%125.99M | -24.53%55.86M | -4.54%307.72M |
| Minority profit | 56.20%-40.54K | -5,439.95%-326.73K | -0.29%-142.8K | 29.05%-65.18K | ---92.55K | ---5.9K | ---142.39K | ---91.88K | ---- | ---- |
| Profit attributable to shareholders | 5.20%58.07M | -55.01%124.99M | -66.14%61.15M | -37.32%79.03M | -1.18%55.2M | -9.72%277.82M | -13.87%180.62M | -19.69%126.08M | -24.53%55.86M | -4.54%307.72M |
| Basic earnings per share | 7.14%0.15 | -54.17%0.33 | -65.96%0.16 | -36.36%0.21 | -6.67%0.14 | -10.00%0.72 | -14.55%0.47 | -19.51%0.33 | -21.05%0.15 | -13.98%0.8 |
| Diluted earnings per share | 7.14%0.15 | -54.17%0.33 | -65.96%0.16 | -36.36%0.21 | -6.67%0.14 | -10.00%0.72 | -14.55%0.47 | -19.51%0.33 | -21.05%0.15 | -13.98%0.8 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion |
| Auditor | -- | Daxin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Daxin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Daxin Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.